Just noticed something interesting about how the nuclear energy space is reshaping. Two companies—NuScale and Oklo—are basically running different playbooks to disrupt traditional nuclear power, and the market's been treating them wildly differently lately.

So here's what caught my attention. NuScale builds small modular reactors (SMRs) that are compact and prefab—think 65 feet tall, 9 feet wide. They're the only SMR player with actual design approvals from the U.S. Nuclear Regulatory Commission. Their 77 MWe design got approved and is now being deployed for Romania's RoPower project, plus they've locked in a deal with the Tennessee Valley Authority to deploy up to six gigawatts across seven states. Solid progress on paper.

Oklo's taking a different route. Their microreactors are even tinier—1.5 MWe individually—but you can chain them together to hit 15-100 MWe per deployment. The real kicker? They use metallic uranium fuel instead of traditional uranium dioxide, which means the reactors can run about a decade without refueling versus every two years for conventional setups. Oklo already broke ground on their first Idaho reactor last year and landed a government contract for Eielson Air Force Base in Alaska.

Here's where it gets interesting though. Neither company is actually making money yet. NuScale's first reactors won't come online until the early 2030s. Until then, they're living off FEED studies and licensing deals—analysts expect revenue to climb from $31 million to $287 million between 2025-2028, but that's pocket change compared to what's coming. Oklo won't generate revenue until late 2027 when their Idaho reactor deploys, with projections around $16 million that year.

But here's the valuation puzzle that's been bugging me. Oklo's trading at a $9.7 billion market cap—that's over 600 times its projected 2027 sales. NuScale's at $3.9 billion, which sounds cheaper at 19 times 2027 sales, but both are expensive for companies that won't be operational for years. The market seems to be rewarding Oklo's faster timeline and technical edge, even though NuScale has regulatory approvals and near-term catalysts that are easier to track.

What I find compelling is that both could actually coexist. Oklo's targeting smaller, remote deployments. NuScale's building larger modular plants. They're not necessarily in direct competition. The real question is whether investors have the patience for these multi-year timelines, or if the next market correction punishes both again. Right now, the market's betting on Oklo's momentum carrying forward, but NuScale's regulatory wins and TVA contract could become huge catalysts once we get closer to 2030s deployments.

Worth keeping tabs on if you're thinking about the long-term energy transition play.